NC1153

CAS No. 150661-91-9

NC1153( NC-1153 | NC 1153 )

Catalog No. M12100 CAS No. 150661-91-9

A Mannich base compound, selective and orally active JAK3 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NC1153
  • Note
    Research use only, not for human use.
  • Brief Description
    A Mannich base compound, selective and orally active JAK3 inhibitor.
  • Description
    A Mannich base compound, selective and orally active JAK3 inhibitor that blocks IL-2-induced activation of JAK3 and downstream substrates STAT5a/b; fails to inhibit several other enzymes, including growth factor receptor tyrosine kinases, Src family members, and serine/threonine protein kinases; inhibits proliferation of normal human T cells challenged with IL-2, IL-4, or IL-7; significantly extends survival of MHC/non-MHC mismatched rat kidney allografts, induces transplantation tolerance in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NC-1153 | NC 1153
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    JAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    150661-91-9
  • Formula Weight
    369.415
  • Molecular Formula
    C18H38Cl2N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C(CN(C)C)CCCCCCCCCC1CN(C)C
  • Chemical Name
    2,12-bis((dimethylamino)methyl)cyclododecan-1-one dihydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Stepkowski SM, et al. J Immunol. 2005 Oct 1;175(7):4236-46. 2. Nagy ZS, et al. Mol Cancer. 2009 Aug 26;8:67. 3. Nagy ZS, et al. FEBS Lett. 2010 Apr 16;584(8):1515-20.
molnova catalog
related products
  • Ruxolitinib S enanti...

    The chirality of Ruxolitinib (INCB-018424), which is a potent, selective, orally active JAK1/JAK2 inhibitor.

  • JAK2 inhibitor G5-7

    JAK2 inhibitor G5-7 is a small molecule, allosteric JAK2 inhibitor.

  • PF-04965842

    PF-04965842 (Abrocitinib, PF04965842) is a potent, selective, orally bioavailable JAK1 inhibitor with IC50 of 29 nM.